Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernesto Canalis

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
European Journal of Endocrinology|November 9, 2017
MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosisErnesto Canalis
Current Opinion in Rheumatology|June 24, 2003
Mechanisms of glucocorticoid-induced osteoporosisErnesto Canalis
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 31, 2010
New treatment modalities in osteoporosisErnesto Canalis
Nature Reviews. Endocrinology|August 14, 2013
Wnt signalling in osteoporosis: mechanisms and novel therapeutic approachesErnesto Canalis
Science Signaling|May 1, 2008
Notch signaling in osteoblastsErnesto Canalis
Annals of the New York Academy of Sciences|December 18, 2007
Nephroblastoma overexpressed (Nov) is a novel bone morphogenetic protein antagonistErnesto Canalis
Journal of Cellular Biochemistry|September 1, 2009
Growth factor control of bone massErnesto Canalis
Metabolism: Clinical and Experimental|September 25, 2017
Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disordersErnesto Canalis
Current Osteoporosis Reports|September 1, 2005
Mechanisms of glucocorticoid action in boneErnesto Canalis
The Journal of Clinical Endocrinology and Metabolism|April 9, 2010
Update in new anabolic therapies for osteoporosisErnesto Canalis
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Endocrinology|November 9, 2017
MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosisErnesto Canalis
Current Opinion in Rheumatology|June 24, 2003
Mechanisms of glucocorticoid-induced osteoporosisErnesto Canalis
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 31, 2010
New treatment modalities in osteoporosisErnesto Canalis
Nature Reviews. Endocrinology|August 14, 2013
Wnt signalling in osteoporosis: mechanisms and novel therapeutic approachesErnesto Canalis
Science Signaling|May 1, 2008
Notch signaling in osteoblastsErnesto Canalis
Annals of the New York Academy of Sciences|December 18, 2007
Nephroblastoma overexpressed (Nov) is a novel bone morphogenetic protein antagonistErnesto Canalis
Journal of Cellular Biochemistry|September 1, 2009
Growth factor control of bone massErnesto Canalis
Metabolism: Clinical and Experimental|September 25, 2017
Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disordersErnesto Canalis
Current Osteoporosis Reports|September 1, 2005
Mechanisms of glucocorticoid action in boneErnesto Canalis
The Journal of Clinical Endocrinology and Metabolism|April 9, 2010
Update in new anabolic therapies for osteoporosisErnesto Canalis
Pageof 14